2016 to 2020 Did Not See Any Improvement in Takotsubo Cardiomyopathy Outcomes
By Lori Solomon HealthDay Reporter
FRIDAY, May 16, 2025 -- Takotsubo cardiomyopathy is associated with high mortality and complications, and recent years have seen little to no improvement in outcomes, according to a study published online May 14 in the Journal of the American Heart Association.
Mohammad Reza Movahed, M.D., Ph.D., from the University of Arizona Sarver Heart Center in Tucson, and colleagues evaluated outcomes for patients with Takotsubo cardiomyopathy. The analysis included data from 199,890 patients with Takotsubo identified through the Nationwide Inpatient Sample (2016 to 2020).
The researchers found that 83 percent of identified patients were female. Higher prevalence was also seen with age, White race, and highest income. Mortality was 6.5 percent, with no significant improvement noted during the study period. Men had doubled mortality compared with women (11.2 versus 5.5 percent). Major complications were substantial, including cardiogenic shock (6.6 percent), atrial fibrillation (20.7 percent), cardiac arrest (3.4 percent), congestive heart failure (35.9 percent), and stroke (5.3 percent).
"Takotsubo cardiomyopathy is a serious condition with a substantial risk of death and severe complications," Movahed said in a statement. "The health care team needs to carefully review coronary angiograms that show no significant coronary disease with classic appearance of left ventricular motion, suggesting any subtypes of stress-induced cardiomyopathy. These patients should be monitored for serious complications and treated promptly."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Follow-Up on Blood-Based Colorectal Cancer Screening Results Is Low
TUESDAY, Aug. 5, 2025 -- Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within...
Current Medical Use of Rx Stimulants for ADHD Up in Teens From 2005 to 2023
TUESDAY, Aug. 5, 2025 -- Among U.S. adolescents, current medical use of prescription stimulants for attention-deficit/hyperactivity disorder (ADHD) increased between 2005 and...
Study Estimates Global Burden of Vertically Transmitted Hepatitis C
TUESDAY, Aug. 5, 2025 -- Each year, nearly 74,000 children are born with hepatitis C virus (HCV) around the world, according to a study published online July 23 in The Lancet...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.